Voya Investment Management LLC Sells 154 Shares of Revvity Inc. $RVTY

Voya Investment Management LLC decreased its stake in Revvity Inc. (NYSE:RVTY) by 0.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,820 shares of the company’s stock after selling 154 shares during the period. Voya Investment Management LLC’s holdings in Revvity were worth $3,684,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of RVTY. Vermillion Wealth Management Inc. bought a new position in Revvity in the fourth quarter valued at approximately $41,000. New Age Alpha Advisors LLC bought a new position in shares of Revvity in the first quarter valued at $44,000. Continuum Advisory LLC grew its stake in shares of Revvity by 39.3% in the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company’s stock valued at $53,000 after buying an additional 133 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Revvity by 25.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock worth $73,000 after buying an additional 140 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC bought a new stake in Revvity during the first quarter worth $75,000. Institutional investors own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on RVTY. Bank of America lowered their price objective on shares of Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Stifel Nicolaus reduced their price target on Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a report on Tuesday, July 29th. Evercore ISI dropped their price objective on Revvity from $116.00 to $115.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Raymond James Financial reaffirmed an “outperform” rating and issued a $115.00 price objective (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Finally, Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Ten investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Revvity presently has an average rating of “Moderate Buy” and an average target price of $120.07.

Revvity Price Performance

Revvity stock opened at $86.68 on Friday. The stock’s 50 day moving average is $90.03 and its 200 day moving average is $95.31. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity Inc. has a one year low of $81.36 and a one year high of $129.50. The firm has a market cap of $10.06 billion, a P/E ratio of 36.73, a P/E/G ratio of 2.36 and a beta of 0.94.

Revvity (NYSE:RVTY) last released its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same quarter in the previous year, the business earned $1.22 earnings per share. Revvity’s revenue for the quarter was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, research analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.